Study of efficacy and antibody duration to fourth-dose booster of Ad5-nCoV or inactivated SARS-CoV-2 vaccine in Chinese adults: a prospective cohort study
Description
INTRODUCTION: China experienced a record surge of coronavirus disease 2019 cases in December 2022, during the pandemic.
